PSI Newsletter

The PSI Newsletter is a regular email communication that contains information and events of interest to the profession and wider stakeholders. If you wish to be added to the newsletter subscriber list you can sign up here.

PSI Newsletter: Issue 4, 2018

  • Review of the operation of the Pharmacy Assessment System
  • Fitness to practise outcome
  • Falsified Medicines Directive- medicines authentication
  • Adrenaline Auto Injectors
  • APPEL- student placements
  • Experienced vaccinator training requirements
  • Opioid Substitution Therapy: Introduction of Buprenorphine/Naloxone
  • Changes to PSI Advisory Committees
  • PSI Guidance for Pharmacists on the Safe Supply of Sumatriptin 50mg Tablets
  • European Medicines Agency recommendation on Quinolone and Fluoroquinolone
  • Healthcare Professionals Crossing Borders (HPCB) Conference 2019

PSI Newsletter: Issue 3, 2018

  • Recent PSI public consultations
  • Annual Report 2017
  • Notice from Irish Medicines Verification Organisation
  • Oral methotrexate: Reminder to counsel women and men on pregnancy prevention
  • Reminder: Inspectors' advice on error management
  • Reminder: ePortfolio Review 2018/2019
  • Reminder: NPIP sign-off by tutors
  • New online information repository on medical cannabis
  • Update to Immunisation Guidelines
  • Improving the management of medicines shortages

PSI Newsletter: Issue 2, 2018

  • PSI public consultations
  • Fitness to practise outcomes
  • Appointments to Council
  • Frequently asked questions
  • Updated guidelines
  • Review of the Pharmacy Assessment System
  • Emergency medicines and vaccination training requirements
  • Salbutamol inhalers on list of interchangeable medicines
  • PSI recruitment
  • Reminder:change of ownership
  • Superintendent pharmacist seminars
  • National Pharmacy Internship Programme (NPIP) application process

PSI Newsletter: Issue 1, 2018

  • Publication of PSI Corporate Strategy 2018-2020
  • Reminder - food intolerance testing not appropriate in pharmacies
  • Medicine safety: risks of topiramate use during pregnancy
  • GDPR considerations for pharmacists
  • Fitness to practise outcomes
  • PSI recruitment: pharmacy inspector sought
  • Registration updates
  • HPRA safety notice regarding head-lice treatment products
  • Student placement notice for interested tutors - APPEL
  • Reminder about appropriate storage of pharmacy-only medicines
  • New resources for pharmacists and patients from HSE's Medicines Management Programme
  • Update to national vaccination guidelines
  • PSI signs MOU with Northern Ireland pharmacy regulator
  • Vaccination reminder for healthcare professional

View previous issues of the PSI Newsletter